The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders

Molecular Therapy. Methods & Clinical Development
Christopher B ChambersAndrew Wilber

Abstract

Sickle cell disease (SCD) and β-thalassemia are caused by structural abnormality or inadequate production of adult hemoglobin (HbA, α2β2), respectively. Individuals with either disorder are asymptomatic before birth because fetal hemoglobin (HbF, α2γ2) is unaffected. Thus, reversal of the switch from HbF to HbA could reduce or even prevent symptoms these disorders. In this study, we show that insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is one factor that could accomplish this goal. IGF2BP1 is a fetal factor that undergoes a transcriptional switch consistent with the transition from HbF to HbA. Lentivirus delivery of IGF2BP1 to CD34+ cells of healthy adult donors reversed hemoglobin production toward the fetal type in culture-differentiated erythroid cells. Analogous studies using patient-derived CD34+ cells revealed that IGF2BP1-dependent HbF induction could ameliorate the chain imbalance in β-thalassemia or potently suppress expression of sickle β-globin in SCD. In all cases, fetal γ-globin mRNA increased and adult β-globin decreased due, in part, to formation of contacts between the locus control region (LCR) and γ-globin genes. We conclude that expression of IGF2BP1 in adult erythroid cells has the potentia...Continue Reading

References

Sep 11, 1997·The New England Journal of Medicine·H F Bunn
Oct 3, 1999·Nature Biotechnology·M V MatzS A Lukyanov
Feb 28, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hideki HanawaArthur W Nienhuis
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Suzan ImrenR Keith Humphries
May 4, 2004·Molecular and Cellular Biology·Thomas V O HansenFinn C Nielsen
Dec 17, 2004·Biology of the Cell·Joel K Yisraeli
Feb 26, 2005·Experimental Hematology·George Stamatoyannopoulos
Oct 6, 2005·Bone Marrow Transplantation·G La NasaL Contu
Dec 13, 2005·Annals of the New York Academy of Sciences·Javid GazievGuido Lucarelli
Feb 10, 2007·Molecular & Cellular Proteomics : MCP·Lars JønsonFinn C Nielsen
Jun 7, 2007·Current Biology : CB·Eric G Moss
Jul 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paritha I ArumugamPunam Malik
Dec 4, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tamara I PestinaDerek A Persons
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chunhui HouAnn Dean
Apr 7, 2009·British Journal of Haematology·Swee Lay Thein, Stephan Menzel
May 12, 2009·Journal of Molecular Endocrinology·Jan ChristiansenFinn C Nielsen
Jun 2, 2009·Nature Genetics·Srinivas R ViswanathanGeorge Q Daley
Aug 7, 2009·Nature·Vijay G SankaranStuart H Orkin
Sep 24, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Tang-Her JaingPei-Kwei Tsay
Jul 29, 2010·EMBO Molecular Medicine·Emanuela Anna RoselliGiuliana Ferrari
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Oct 17, 2012·Cellular and Molecular Life Sciences : CMLS·Jessica L BellStefan Hüttelmaier
Jul 19, 2013·The Journal of Clinical Investigation·Zulema RomeroDonald B Kohn
Mar 15, 2015·Current Opinion in Hematology·Mark C Walters
Jun 25, 2015·British Journal of Haematology·Martin H Steinberg, Griffin P Rodgers
Dec 15, 2015·Molecular Therapy. Methods & Clinical Development·Tamara I PestinaDerek A Persons

❮ Previous
Next ❯

Citations

Nov 5, 2020·Immunological Reviews·Maria PapadopoulouDavid Vermijlen
Aug 19, 2020·Blood·Martin H Steinberg

❮ Previous
Next ❯

Methods Mentioned

BETA
ChIP
acetylation
immunoprecipitation
flow cytometry
fluorescence-activated cell sorting
FACS
electrophoresis
PCR
transfection

Software Mentioned

GraphPad Prism
IDT
Excel
FlowJo

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Advances in Experimental Medicine and Biology
Shuaiying Cui, James Douglas Engel
Mediterranean Journal of Hematology and Infectious Diseases
Marco Gabbianelli, Ugo Testa
Proceedings of the National Academy of Sciences of the United States of America
Jaira F de VasconcellosJeffery L Miller
© 2021 Meta ULC. All rights reserved